Cloning and Characterization of Immunological Properties of Haemophilus influenzae Enolase
Author(s) -
Yesenia Osorio-Aguilar,
María Cristina GonzálezVázquez,
Patricia Lozano-Zaraín,
Ygnacio MartínezLaguna,
Alejandro CarabarínLima,
Rosa del Carmen RochaGracia
Publication year - 2021
Publication title -
journal of immunology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 83
eISSN - 2314-8861
pISSN - 2314-7156
DOI - 10.1155/2021/6629824
Subject(s) - haemophilus influenzae , epitope , microbiology and biotechnology , biology , virology , enolase , serotype , polyclonal antibodies , antibody , immune system , epitope mapping , immunology , immunohistochemistry , antibiotics
Haemophilus influenzae is a common organism of the human upper respiratory tract; this bacterium is responsible of a wide spectrum for respiratory infections and can generate invasive diseases such as meningitis and septicemia. These infections are associated with H. influenzae encapsulated serotype b. However, the incidence of invasive disease caused by nontypeable H. influenzae (NTHi) has increased in the post- H. influenzae serotype b (Hib) vaccine era. Currently, an effective vaccine against NTHi is not available; due to this, it is important to find an antigen capable to confer protection against NTHi infection. In this study, 10 linear B cell epitopes and 13 CTL epitopes and a putative plasminogen-binding motif ( 252 FYNKENGMY 260 ) and the presence of enolase on the surface of different strains of H. influenzae were identified in the enolase sequence of H. influenzae . Both in silico and experimental results showed that recombinant enolase from H. influenzae is immunogenic that could induce a humoral immune response; this was observed mediating the generation of specific polyclonal antibodies anti-rNTHiENO that recognize typeable and nontypeable H. influenzae strains. The immunogenic properties and the superficial localization of enolase in H. influenzae , important characteristics to be considered as a new candidate for the development of a vaccine, were demonstrated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom